Paolo Tonucci, Chief Strategist and CEO of Capital Markets at Marex Group Ltd, filed a Form 4 on November 12, 2026, reporting the sale of 16,668 ordinary shares on November 9, 2026, pursuant to a Rule 10b5-1 plan.

Key Highlights

  • Three separate sale tranches: Tonucci disposed of 3,196 shares at a weighted average price of $67.8914, 10,760 shares at $68.7356, and 2,712 shares at $69.4058, all on November 9, 2026.
  • Post-transaction ownership: Following the sales, Tonucci directly beneficially owned 1,236,237 ordinary shares, according to the filing.
  • Unvested awards included: The post-transaction share count includes 220,746 shares underlying unvested deferred bonus plan awards, each representing a contingent right to receive one ordinary share upon vesting and settlement.
  • 10b5-1 plan: The sales were effected pursuant to a Rule 10b5-1 plan entered into by Tonucci on October 22, 2025.
  • Price ranges disclosed: Individual transaction prices ranged from $67.175 to $68.1625 for the first tranche, $68.1775 to $69.1725 for the second, and $69.175 to $69.885 for the third.

Tonucci's November 9 Share Sales at Marex Group

According to the Form 4 filed with the SEC, Paolo Tonucci, identified in the filing as Chief Strategist and CEO of Capital Markets at Marex Group Ltd (NASDAQ:MRX), reported three dispositions of ordinary shares on November 9, 2026. The transactions were coded "S" (sale) and carried out as direct holdings. The combined total of shares sold across all three tranches was 16,668.

The filing states that all sales were made pursuant to a Rule 10b5-1 plan that Tonucci entered into on October 22, 2025. The weighted average prices reported were $67.8914 for 3,196 shares, $68.7356 for 10,760 shares, and $69.4058 for 2,712 shares. Because these are weighted averages, the filing notes that individual sale prices within each tranche spanned a range, and the reporting person has undertaken to provide full per-price detail to the issuer, any security holder, or SEC staff upon request.

After accounting for all three transactions, the filing reports Tonucci's direct beneficial ownership at 1,236,237 ordinary shares. The filing clarifies that this figure includes 220,746 shares underlying unvested deferred bonus plan awards previously granted to Tonucci, with each award described as "a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award." No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

The filing disclosed three Rule 10b5-1 sales of Marex Group ordinary shares by Paolo Tonucci on November 9, 2026, totaling 16,668 shares at weighted average prices between $67.8914 and $69.4058, with post-transaction direct beneficial ownership of 1,236,237 shares.